Howe Jolanda

SVP, GLOBAL CONTROLLERMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$327K
Net Open-Market Flow
-$327K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)3K$120.00$327K3K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001974200-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly: